Skip to main content
. Author manuscript; available in PMC: 2012 Aug 13.
Published in final edited form as: Biosens Bioelectron. 2007 Dec 14;23(10):1413–1421. doi: 10.1016/j.bios.2007.11.022

Figure 3.

Figure 3

Scatter plots of the level of antibodies to the citrullinated peptide or non-citrullinated peptide in the RA, normal control (NC) and osteoarthritic (OA) patient groups as measured by the three assay systems (nanotube, ELISA and microarray). The normal cut-off is indicated below the horizontal dashed line, and presented is also the mean ± s.e.m. for each serum sample group in each assay.